Sprouts Launches Bold Lawsuit Challenging Insulin Pricing
Sprouts files lawsuit over insulin pricing scheme and PBM collusion.
Industry Trends
UK Government Unlocks Game-Changing Drug Pricing Strategy
UK braces as drug pricing shifts dramatically in market access landscape.
Regeneron Unlocks Game-Changing Multispecific Antibody Pact
Regeneron boosts its pipeline with multispecific platform for disease innovation.
Thermo Fisher’s Inspiring $10 Billion Acquisition of Clario
Thermo Fisher acquisition hits billion mark for Clario.
HAS Stroke Update Transforms Access on World Stroke Day
HAS strengthens stroke management for faster, equitable emergency care access.
Reimbursement Series: Anchors Affordable Breakthroughs – AIFA and TLV Expand European Coverage
Sweden expands reimbursement decisions driving biotech access and patient impact.
NICE Secures Breakthrough HTA Decision for Prostate Cancer
NICE issues breakthrough HTA decision on Bayer’s prostate cancer therapy.
NICE accelerates breakthrough framework for complex liver diseases
NICE drives innovation, reshaping MASH evaluations with transformative guidance.
Novartis secures triumphant $12 billion takeover of Avidity
The billion-dollar acquisition advances Avidity’s RNA platform with momentum.
Biogen Secures Breakthrough Edge in Immunology with $1B Vanqua Buy
Biogen strengthens Immunology pipeline through $1B Vanqua acquisition deal.